Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Schrodinger, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Pharmaceutical Preparations
Prev close 23.20 · gapped below the open, then crossed back over prior close. High/low 23.53 at 3:30 pm ET, 20.34 at 8:15 am ET.
Schrodinger, Inc. has 4 disclosed suppliers and 8 disclosed customers. Each one is named in an SEC filing, either Schrodinger, Inc.’s own annual report or the counterparty’s, and carries the sentence that discloses it.
Sources
sec edgar · verbatim disclosureEach tie, with the sentence that disclosed it. Open a row for the wording and the filing it came from.
“The project is being funded initially by $19.5 million in grants from the Bill & Melinda Gates Foundation.”
FILING10-K0001490978-26-000010cik 0001490978
“We are party to an exclusive, worldwide collaboration and license agreement with BMS, pursuant to which we and BMS agreed to collaborate in the discovery, research and development of small molecule compounds for biological targets in the oncology, neurology and immunology therapeutic areas.”
FILING10-K0001490978-26-000010cik 0001490978
“In September 2022, we entered into a collaboration with Lilly under which we are responsible for the discovery and optimization of small molecule compounds addressing an immunology target.”
FILING10-K0001490978-26-000010cik 0001490978
“In November 2024, we also entered into an expanded three-year software agreement with Novartis that substantially increases Novartis' access to our computational predictive modeling technology and enterprise informatics platform.”
FILING10-K0001490978-26-000010cik 0001490978
“In particular, the technology that we license from Columbia University pursuant to our license agreements with them are used in and incorporated into a number of our software solutions which we market and license to our customers.”
FILING10-K0001490978-26-000010cik 0001490978
“The agreement with Gates Ventures, LLC was originally entered into in June 2020 and further extended through August 13, 2026.”
FILING10-K0001490978-26-000010cik 0001490978
“For example, in 2023, we entered into a research collaboration with Copernic Catalysts, Inc. to help accelerate the discovery and development of sustainable catalysts for applications in e-fuels and bulk chemicals.”
FILING10-K0001490978-26-000010cik 0001490978
“As part of our ongoing efforts to further advance our software solutions for materials science applications, in June 2020, we entered into a three-year agreement with Gates Ventures, LLC, or Gates Ventures, to develop and apply atomistic simulations methods to improve battery performance.”
FILING10-K0001490978-26-000010cik 0001490978
“We are also entitled to low single-digit royalties on our clinical development programs under our collaboration agreement with Morphic, including MORF-057.”
FILING10-K0001490978-26-000010cik 0001490978
“For example, in collaboration with us, Nimbus was able to identify a unique series of acetyl-CoA carboxylase, or ACC, allosteric protein-protein interaction inhibitors with favorable pharmaceutical properties that inhibit the activity of the ACC enzyme.”
FILING10-K0001490978-26-000010cik 0001490978
“In January 2025, we announced that we have expanded the collaboration with Otsuka to add an undisclosed target to the collaboration.”
FILING10-K0001490978-26-000010cik 0001490978
“In 2023, on account of our equity stake in Nimbus Therapeutics, LLC, or Nimbus, we received an aggregate of $147.2 million in cash distributions from Nimbus in connection with Takeda's acquisition of Nimbus Lakshmi, Inc., a wholly-owned subsidiary of Nimbus, and its TYK2 inhibitor NDI-034858.”
FILING10-K0001490978-26-000010cik 0001490978
Watchlist prices, news filtered to it, and its next report on your desk.
SDGR (Schrodinger, Inc.) has 4 disclosed suppliers and 8 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: NVS +0.51%, in healthcare.